1. HBW Insight
  2. >>Ingredients & Safety

CIR Experts Close Book (For Now) On Parabens: Safe Individually Or At Sum Concentration Of ≤0.8%

 
• By Ryan Nelson

NGO Women’s Voices for the Earth supports the 0.8% limit on total parabens content adopted by the Cosmetic Ingredient Review Expert Panel at its 16-17 September meeting. WVE remains concerned, however, about certain assumptions made by the panel in the lengthy re-review process that led to its final amended report.

Petri dish

The Cosmetic Ingredient Review Expert Panel issued a final amended report 17 September for 20 parabens, determining them safe as currently used when the sum of paraben concentrations in a final formulation does not exceed 0.8%.

The limit on total parabens content represents a departure from previous CIR panel assessments, which have repeatedly found groups of...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Ingredients & Safety

UK FSA Issues New Guidelines For CBD And THC Max Levels

 
• By David Ridley

Based on advice from its advisory committees, the UK's Food Standards Agency is encouraging businesses to meet an acceptable daily intake of 10mg CBD per day and a safe upper limit of 0.07mg THC per day.

AESGP Annual Meeting: Harmonizing EU VMS Max Levels Could Cost Sector Over €200m

 
• By David Ridley

Limited capacity and a two-to-three year timescale for reformulation could mean that many VMS supplements disappear from the market, warns EPPA partner Alexandra Bocquillion, speaking at the AESGP Annual Meeting in Warsaw, Poland.

EU Pharma Reform: Council Proposes Rx Exemption For Topical Antimicrobials

 
• By David Ridley

The EU Council has introduced a key amendment to Article 51 (para 1, point e) of the new pharma directive: “A medicinal product shall be subject to medical prescription where it is an antimicrobial, unless intended for topical use.”

Review Suggests Advantage Of Bayer’s Iberogast Advance For Digestive Disorders

 
• By David Ridley

Bayer's Iberogast Advance's combination of six herbal ingredients may produce a synergistic effect that acts on multiple underlying issues contributing to digestive disorders like functional dyspepsia (FD) and irritable bowel syndrome (IBS), a recently published study suggests.

More from HBW Insight

Lupin Goes For Growth With Indian Consumer Health Spin-Off

 
• By Tom Gallen

With annual sales approaching $20m, LupinLife Consumer Healthcare has ambitious growth plans for the Indian OTC market.

L’Oréal Plans Purchase Of Color Wow Brand

 
• By Eileen Francis

L’Oréal has signed an agreement to acquire the Color Wow professional styling brand for an undisclosed price.

US FDA’s Tough Talk On Talc: Regulating In An Echo Chamber

 
• By Michael McCaughan

An FDA “expert roundtable” on talc produced a new talking point on a potential drug safety risk, but the basis of that claim is difficult to determine.